Polyhydroxybutyrate-co-hydroxyvalerate has been identified as a useful polymer for biomedical application due to its biocompatibility and processability. Polyhydroxybutyrate-co-hydroxyvalerate nanoparticles loaded with quercetin, an antimicrobial, anti-inflammatory, and antiviral polyphenol with limited solubility, were obtained using a high-speed double-emulsion technique. The nanoparticle size and the dissolution of quercetin were controlled simultaneously through high-speed stirring (15,000 r/min) in the emulsification process. The size range of quercetin-loaded polyhydroxybutyrate-co-hydroxyvalerate nanoparticles was between 250 and 650 nm. Spherical shape with no aggregation of nanoparticles was confirmed by electron microscopy. Loaded nanoparticles showed less thermal degradation than unloaded nanoparticles. An encapsulation efficiency of 51% was found. Most of the quercetin was released from the nanoparticles within the first 5 h of water immersion. A biocompatibility analysis of the nanoparticles showed no cytotoxicity and no significant difference between loaded and unloaded nanoparticles.
Ram Kumar PandianSDeepakVKalishwaralalK. Synthesis of PHB nanoparticles from optimized medium utilizing dairy industrial waste using Brevibacterium casei SRKP2: a green chemistry approach. Colloids Surf B Biointerfaces2009; 74: 266–273.
2.
ChenG-QWuQ.The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials2005; 26: 6565–6578.
3.
BaranETOzerNHasirciV.Poly(hydroxybutyrate-co-hydroxyvalerate) nanocapsules as enzyme carriers for cancer therapy: an in vitro study. J Microencapsul2002; 19: 363–376.
4.
UedaHTabataY.Polyhydroxyalkanonate derivatives in current clinical applications and trials. Adv Drug Deliv Rev2003; 55: 501–518.
5.
ZinnMWitholtBEgliT.Occurrence, synthesis and medical application of bacterial polyhydroxyalkanoate. Adv Drug Deliv Rev2001; 53: 5–21.
6.
MuruevaAVShishatskayaEIKuzminaAM. Microparticles prepared from biodegradable polyhydroxyalkanoates as matrix for encapsulation of cytostatic drug. J Mater Sci Mater Med2013; 24: 1905–1915.
7.
PaşcuEIStokesJMcGuinnessGB.Electrospun composites of PHBV, silk fibroin and nano-hydroxyapatite for bone tissue engineering. Mater Sci Eng C Mater Biol Appl2013; 33: 4905–4916.
8.
PichASchiemenzNCortenC. Preparation of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) particles in O/W emulsion. Polymer2006; 47: 1912–1920.
9.
PolettoFSFielLADonidaB. Controlling the size of poly(hydroxybutyrate-co-hydroxyvalerate) nanoparticles prepared by emulsification–diffusion technique using ethanol as surface agent. Colloids Surf A Physicochem Eng Asp2008; 324: 105–112.
10.
MasoodFChenPYasinT. Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application. Mater Sci Eng C Mater Biol Appl2013; 33: 1054–1060.
11.
VilosCMoralesFASolarPA. Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells. Biomaterials2013; 34: 4098–4108.
12.
BaranETOzerNHasirciV.In vivo half life of nanoencapsulated L-asparaginase. J Mater Sci Mater Med2002; 13: 1113–1121.
13.
FangZBhandariB.Encapsulation of polyphenols—a review. Trends Food Sci Technol2010; 21: 510–523.
14.
HolmesPA.Applications of PHB—a microbially produced biodegradable thermoplastic. Phys Tech1985; 16: 32–36.
15.
HolmesPA.Biologically produced (R)-3-hydroxy-alkanoate polymers and copolymers. In: BassettDC (ed.) Developments in crystalline polymers. Dordrecht: Springer, 1988, pp. 1–65.
16.
Rodríguez-ContrerasACanalCCalafell-MonfortM. Methods for the preparation of doxycycline-loaded phb micro- and nano-spheres. Eur Polym J2013; 49: 3501–3511.
17.
LionzoMIZRéMIGuterresSS. Microparticles prepared with poly(hydroxybutyrate-co-hydroxyvalerate) and poly(epsilon-caprolactone) blends to control the release of a drug model. J Microencapsul2007; 24: 175–186.
18.
MuninAEdwards-LévyF.Encapsulation of natural polyphenolic compounds; a review. Pharmaceutics2011; 3: 793–829.
19.
KumariAYadavSKPakadeYB. Development of biodegradable nanoparticles for delivery of quercetin. Colloids Surf B Biointerfaces2010; 80: 184–192.
20.
SousaFGuebitzGMKokolV.Antimicrobial and antioxidant properties of chitosan enzymatically functionalized with flavonoids. Process Biochem2009; 44: 749–756.
21.
CushnieTPTLambAJ. Antimicrobial activity of flavonoids. Int J Antimicrob Agents2005; 26: 343–356.
22.
FranceskoASoaresdaCostaDReisRL. Functional biopolymer-based matrices for modulation of chronic wound enzyme activities. Acta Biomater2013; 9: 5216–5225.
23.
MiddletonJEChithanK. The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In: HarborneJ (ed.) The flavonoids: advances in research since 1986. London: Chapman & Hall, 1993, pp. 619–652.
24.
SelwayJ.Antiviral activity of flavones and flavans. Prog Clin Biol Res1986; 213: 521–536.
25.
OnoKNakaneHFukushimaM. Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur J Biochem1990; 190: 469–476.
26.
CarliLNCrespoJSMaulerRS.PHBV nanocomposites based on organomodified montmorillonite and halloysite: the effect of clay type on the morphology and thermal and mechanical properties. Compos Part A Appl Sci Manuf2011; 42: 1601–1608.
GalalIEl-HindawyK.Impact of using triclosan-antibacterial sutures on incidence of surgical site infection. Am J Surg2011; 202: 133–138.
29.
PekalAPyrzynskaK.Evaluation of aluminium complexation reaction for flavonoid content assay. Food Anal Method2014; 7: 1776–1782.
30.
TorresSKCamposVLLeónCG. Biosynthesis of selenium nanoparticles by Pantoea agglomerans and their antioxidant activity. J Nanopart Res2012; 14: 1236.
31.
GonzálezMRojasSAvilaP. Insulin reverses D-glucose-increased nitric oxide and reactive oxygen species generation in human umbilical vein endothelial cells. PLoS ONE2015; 10: e0122398.
32.
ForootanfarHAdeli-SardouMNikkhooM. Antioxidant and cytotoxic effect of biologically synthesized selenium nanoparticles in comparison to selenium dioxide. J Trace Elem Med Biol2014; 28: 75–79.
33.
HöferPVermettePGroleauD.Production and characterization of polyhydroxyalkanoates by recombinant Methylobacterium extorquens: combining desirable thermal properties with functionality. Biochem Eng J2011; 54: 26–33.
34.
Moreira da CostaEBarbosa FilhoJMGomes do NascimentoT. Thermal characterization of the quercetin and rutin flavonoids. Thermochim Acta2002; 392–393: 79–84.
35.
ZaverlM.Studies on recyclability of polyhydroxybutyrate-co-valerate bioplastic: multiple melt processing and performance evaluations. J Appl Polym Sci2012; 125: E324–E331.
36.
PoutonCWAkhtarS.Biosynthetic polyhydroxyalkanoates and their potential in drug delivery. Adv Drug Deliv Rev1996; 18: 133–162.
37.
LaycockBHalleyPPrattS. The chemomechanical properties of microbial polyhydroxyalkanoates. Prog Polym Sci2014; 39: 397–442.
38.
WangYYamadaSAsakawaN. Comonomer compositional distribution and thermal and morphological characteristics of bacterial poly(3-hydroxybutyrate-co-3-hydroxyvalerate)s with high 3-hydroxyvalerate content. Biomacromolecules2001; 2: 1315–1323.
39.
HuangWWangYRenL. A novel PHBV/HA microsphere releasing system loaded with alendronate. Mater Sci Eng C Mater Biol Appl2009; 29: 2221–2225.
40.
Dinesh KumarVVermaPRPSinghSK. Development and evaluation of biodegradable polymeric nanoparticles for the effective delivery of quercetin using a quality by design approach. LWT—Food Sci Technol2015; 61: 330–338.
41.
Martínez-SanzMVillanoMOliveiraC. Characterization of polyhydroxyalkanoates synthesized from microbial mixed cultures and of their nanobiocomposites with bacterial cellulose nanowhiskers. N Biotechnol2014; 31: 364–376.
42.
Arcos-HernándezMVLaycockBDonoseBC. Physicochemical and mechanical properties of mixed culture polyhydroxyalkanoate (PHBV). Eur Polym J2013; 49: 904–913.
43.
MarchettiFDe SantiCVietriM. Differential inhibition of human liver and duodenum sulphotransferase activities by quercetin, a flavonoid present in vegetables, fruit and wine. Xenobiotica2001; 31: 841–847.
44.
FreeseCSchreinerDAnspachL. In vitro investigation of silica nanoparticle uptake into human endothelial cells under physiological cyclic stretch. Part Fibre Toxicol2014; 11: 68.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
